首页 | 本学科首页   官方微博 | 高级检索  
     

GLP-1及其受体激动剂Exendin-4临床适应症的扩展
引用本文:王晓婧,赵丽艳,孟婧垚,李品颖,邹卫. GLP-1及其受体激动剂Exendin-4临床适应症的扩展[J]. 生物技术通报, 2010, 0(4)
作者姓名:王晓婧  赵丽艳  孟婧垚  李品颖  邹卫
作者单位:石药集团中奇制药技术有限公司,石家庄,050051
摘    要:GLP-1及其受体激动剂Exendin-4是治疗糖尿病的一种理想药物,是近年来新的研究热点之一。近年发现,该类药物可从多个生理角度发挥功能,揭示其临床适应症可能有进一步的扩展空间。对GLP-1及Exendin-4的各种已知和潜在的临床适应症进行了概述,这些适应症除了各型糖尿病外,还包括肥胖症、神经系统和心脏的疾病以及其他各种潜在适应症。

关 键 词:临床适应症  糖尿病  潜在适应症

Expanding the Clinical Indications of GLP-1 and Its Receptor Agonist Exendin-4
Wang Xiaojing,Zhao Liyan,Meng Jingyao,Li Pinying,Zou Wei. Expanding the Clinical Indications of GLP-1 and Its Receptor Agonist Exendin-4[J]. Biotechnology Bulletin, 2010, 0(4)
Authors:Wang Xiaojing  Zhao Liyan  Meng Jingyao  Li Pinying  Zou Wei
Affiliation:Wang XiaojingZhao LiyanMeng JingyaoLi PinyingZou Wei(CSPC Zhongqi Pharmaceutical Technology Co. Ltd.,Shijiazhuang 050051)
Abstract:GLP-1 and its receptor agonist Exendin-4 are more ideal drugs for treating diabetic. They exert its function from different physiological angles,that revealed the possibility of new clinical indications. A comprehensive review was made about the clinical indication of GLP-1 and Exendin-4,including some type diabetic,obesity,nervous system diseases,protection of heart and potential indications.
Keywords:GLP-1  Exendin-4  GLP-1  Exendin-4  Clinical indication  Diabetic  Potential indications
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号